Immunological parameters in patients with Alzheimer's disease;Immunologische Befunde bei Patienten mit Alzheimer'scher Demenz

Neuropsychiatrie

Volumn 10, Issue 3, 1996, Pages 138-139

  Leblhuber, F ^a,d   Walli, J ^a   Tilz, G P ^c   Wachter, H ^b   Fuchs, D ^b  

^a KEPLER UNIVERSITY HOSPITAL   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

^c UNIVERSITY HOSPITAL GRAZ   (Austria)

^d LNK Wagner Jauregg   (Austria)

Author keywords

Alzheimer's dementia; immune activation

Indexed keywords

IMMUNOGLOBULIN A;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE;

EID: 0029861977     PISSN: 09486259     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52, 487-501 (1988).
2. Aisen P.S., K.L. Davis: Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am. J. Psychiatry 151, 1105-1113 (1994).
3. Araga S., H. Kagimoto, K. Funamoto, K. Takahashi: Reduced natural killer cell activity in patients with dementia of the Alzheimer type. Acta Neurol. Scand. 84, 259-263 (1991).
4. Bauer J., S. Strauss, B. Volk, M. Berger: Il-6-mediated events in Alzheimer's disease pathology. Immunology Today 12, 422 (1991).
5. Duguid J.R., C.W. Bohmont, N. Liu, W.W. Tourtelotte: Changes in brain gene expression shared by srapie and Alzheimer's disease. Proc. Nat. Acad. Sci. USA 86, 7260-7264 (1989).
6. Frei K., U.V. Malipiero, T.P. Leist et al.: On the cellular source and function of interleucin-6 produced in the central nervous system. Eur. J. Immunol. 19, 689-694 (1989).
7. Gaskin F., B.S. Kingsley, S.M. Fu: Autoantibodies to neurofibrillary tangels and brain tissue in Alzheimer's disease. Establishment of Epstein-Barr virus-transformed antibody producing cell lines. J. Expt. Med. 1165, 245-250 (1987).
8. Ishii T., S. Haga: Immunoelectron microscopic localisation of immunoglobulins in amyloid fibrils of senile plaques. Acta Neuropathol. 36, 245-249 (1976).
9. Khansari N., H.D. Whitten, Y.K. Chou, H.H. Funderberg: Immunological dysfunction in Alzheimer's disease. Clin. Immunol. Immunop. 75, 246-250 (1995).
10. Lopez O.L, B.S. Rabin, F.J. Huff: Serum autoantibodies in Alzheimer's disease. Acta Neurol. Scand. 84, 441-444 (1991).
11. McKhann G., D. Drachmann, M. Folstein, R. Katzmann, D. Price, E.M. Stadlan: Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force of Alzheimer's disease. Neurology 34, 934-944 (1984).
12. Pirttilä T., S. Mattinen, H. Frey: The decrease of CD8-positive lymphocytes in Alzheimer's disease. J. Neurol. Sci. 107, 160-165 (1992).
13. Rozemuller J.M., F.C. Stam, P. Eikelenboom: Acute phase proteins are present in amorphous plaques in the cerebral but not in the cerebellar cortex of patients with Alzheimer's disease. Neurosci. Lett. 119, 75-78 (1990).
14. Shalit F., B. Sredni, C. Brodie, E. Kott, M. Hberman: T lymphocyte subpopulations and activation markers correlate with severity of Alzheimer's disease. Clin. Immunol. Immnunop. 75, 246-250 (1995).